UBS Group’s Span-America Medical Systems I SPAN Stock Holding History

UBS Group’s Portfolio SPAN Stock Details SPAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-369	Closed	-$8K	–	8459
2017 Q1	$8K	Sell	369 -1,973	-84%	-$40.7K	﹤0.01%	6796
2016 Q4	$43K	Buy	2,342 +1,706	+268%	+$31.5K	﹤0.01%	5957
2016 Q3	$12K	Sell	636 -2,563	-80%	-$46.3K	﹤0.01%	6703
2016 Q2	$57K	Buy	3,199 +1,623	+103%	+$29.4K	﹤0.01%	5433
2016 Q1	$30K	Sell	1,576 -62	-4%	-$1.18K	﹤0.01%	5911
2015 Q4	$32K	Buy	1,638 +1,138	+228%	+$21.4K	﹤0.01%	6293
2015 Q3	$9K	Sell	500 -1,202	-71%	-$21.5K	﹤0.01%	7389
2015 Q2	$31K	Sell	1,702 -12	-0.7%	-$228	﹤0.01%	6473
2015 Q1	$33K	Buy	+1,714	New	+$31K	﹤0.01%	6477

Other funds holding SPAN

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

JIR

James Investment Research Alpha, Ohio $891M AUM 30.4% 1-Year Est. Return

UBS Group's SPAN Position: Q2 2017 in Review

UBS Group sold out of Span-America Medical Systems I (SPAN) in Q2 2017, closing a stake of 369 shares — an estimated $8K sold.

UBS Group first reported a position in SPAN in Q1 2015 and held it in 9 quarters. The position peaked at $57K in Q2 2016. 2 funds tracked by Wall St. Rank hold SPAN as of Q2 2017.

UBS Group reported no remaining Span-America Medical Systems I position as of Q2 2017 after selling out during the quarter.
UBS Group sold 369 Span-America Medical Systems I shares in Q2 2017, an estimated $8K.
UBS Group first reported a position in Span-America Medical Systems I in Q1 2015 and held it in 9 quarters.
UBS Group's Span-America Medical Systems I position peaked at $57K in Q2 2016.
2 funds tracked by Wall St. Rank held Span-America Medical Systems I as of Q2 2017.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.